Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : Xncr save search
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.2%
H: 2.52%
C: 1.3%
year financial results
BeiGene Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Published: 2024-02-26 (Crawled : 12:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.29%
H: 7.38%
C: 6.02%
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: 2.6%
H: 1.87%
C: 0.7%
business year financial results
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published: 2024-02-13 (Crawled : 19:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -3.56%
H: 2.91%
C: -3.34%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.4%
H: 0.23%
C: -0.46%
MGNX | $16.23 5.32% 5.05% 650K
|
Health Technology
|
| O: -5.25%
H: 2.94%
C: 2.18%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
financial
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 00:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.38%
H: 4.02%
C: 2.88%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.94%
H: 2.53%
C: -6.21%
financial results
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.74%
C: 0.74%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 4.23%
H: 0.12%
C: -1.97%
MGNX | $16.23 5.32% 5.05% 650K
|
Health Technology
|
| O: 0.0%
H: 2.13%
C: 1.16%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.39%
H: 4.09%
C: 3.8%
financial results
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -2.23%
H: 2.28%
C: 1.34%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
REPL | $6.41 -0.16% -0.16% 1.2M
|
Health Technology
|
| O: 2.63%
H: 1.14%
C: -2.65%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.14%
H: 4.77%
C: 4.77%
MGNX | $16.23 5.32% 5.05% 650K
|
Health Technology
|
| O: 0.0%
H: 4.19%
C: 2.31%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 2.75%
H: 0.44%
C: -2.72%
financial results
Xencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.82%
H: 0.2%
C: -4.45%
conference financial results
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
Published: 2023-03-29 (Crawled : 22:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.26%
H: 1.38%
C: -0.64%
BCEL P | $0.085 0.0% 670K
|
Health Technology
|
| O: -6.61%
H: 12.5%
C: 8.33%
atrc-101 update financial results
Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-02-23 (Crawled : 22:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.76%
H: 1.16%
C: -0.9%
BCEL P | $0.085 0.0% 670K
|
Health Technology
|
| O: 1.26%
H: 1.24%
C: -3.11%
year financial results
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results
Published: 2022-11-16 (Crawled : 23:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.07%
H: 1.04%
C: -0.8%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -5.85%
H: 5.41%
C: 4.32%
financial results
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
Published: 2022-07-26 (Crawled : 11:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 0.07%
H: 2.75%
C: 0.83%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 0.19%
H: 5.5%
C: 4.93%
sales monjuvi
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 2.08%
H: 1.96%
C: -0.77%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 2.45%
H: 0.92%
C: -2.03%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 2.12%
H: 4.06%
C: 1.39%
results
MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.23%
H: 3.65%
C: 3.65%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: 0.42%
H: 1.77%
C: 1.48%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 1.42%
H: 7.18%
C: 4.52%
financial results report results
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
Published: 2022-01-18 (Crawled : 11:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.31%
H: 1.67%
C: -3.76%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -4.31%
H: 1.1%
C: -0.73%
sales report
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
Published: 2021-11-11 (Crawled : 10:00) - biospace.com/
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -1.55%
results
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $18.35 0.77% 0.76% 480K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $18.04 0.45% 0.44% 180K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.